Ticagrelor Tablets IP 90 Mg – TACOBIL 90

Ticagrelor Tablets IP 90 Mg – Rapid Platelet Inhibition Because Every Second Counts.

TACOBIL 90: The Composition of Ticagrelor 90 mg is a reversible, direct-acting P2Y12 receptor antagonist and inhibits the P2Y12 ADP receptor on platelets, and prevents ADP-mediated activation of the GPIIb/IIIa receptor complex, reducing platelet aggregation.

Recommended by specialists:
Cardiologists: It is preferred to treat the disease associated with Acute Coronary Syndrome (ACS), Myocardial infarction (MI)
General Physicians: It is preferred to treat the disease for long-term prevention in high-risk cardiac patients

Key Benefits of Ticagrelor Tablets IP 90 Mg – TACOBIL 90:
Fast & Potent Platelet Inhibition: It provides a rapid onset of action and inhibits the P2Y12 receptor, preventing platelet aggregation
Superior to Clopidogrel: To reduce the risk of cardiovascular death, myocardial infarction (MI), and stroke in ACS patients and works independently of CYP2C19 metabolism
Dual Benefit in ACS M.anagement: It has been used along with aspirin as dual antiplatelet therapy (DAPT) in ACS and post-PCI cases

INDICATIONS:
Acute Coronary Syndrome
Post Percutaneous Coronary Intervention
Secondary Prevention in High-Risk Patients*